[Failure of poliomyelitis eradication campaign with oral vaccine: there's no vaccination without adherence]
- PMID: 38390018
- PMCID: PMC10879885
- DOI: 10.48327/mtsi.v3i4.2023.402
[Failure of poliomyelitis eradication campaign with oral vaccine: there's no vaccination without adherence]
Abstract
Thirty-five years after its launch, the Global Polio Eradication Initiative has yet to reach its original goal of 2000. Not only is the wild type 1 polio virus still endemic in two countries, but a new outbreak due to viruses derived from the live attenuated virus used for the oral vaccine has been spreading since 2016. The National Immunization Days (NID), during which teams go door-to-door and attract children to be vaccinated, have provoked violent opposition particularly in Northern Nigeria and in the area of India, Pakistan, Afghanistan. In both regions, the same rumor has developed that the vaccine contains sterilizing products, in order to limit the Muslim population. The organizers of the campaign multiplied in vain the NIDs to overcome the resistance, but pockets of insufficiently vaccinated population have persisted. This has allowed the wild virus to remain endemic and the new outbreak of vaccine-derived viruses to progress. We can wonder what the campaign would have become if its organizers had taken the time to reflect and reorient their strategy to rely on the routine vaccination of the Expanded Program on Immunization that does not arouse such opposition.
Trente-cinq ans après son lancement, l'Initiative mondiale pour l’éradication de la poliomyélite n'a toujours pas atteint son but, originellement fixé à l'an 2000. Non seulement le virus sauvage de type 1 de la poliomyélite est toujours endémique dans deux pays, mais une nouvelle épidémie due à des virus dérivés du virus vivant atténué utilisé pour le vaccin oral se propage depuis 2016. Les Journées nationales de vaccination (JNV), au cours desquelles des équipes font du porte-à-porte, tout en vaccinant parfois également dans les rues, ont suscité de violentes oppositions particulièrement dans le nord du Nigéria et dans la zone Inde, Pakistan, Afghanistan. Dans les deux régions, la même rumeur s'est développée selon laquelle le vaccin contiendrait des produits stérilisants, pour limiter la population musulmane. Les organisateurs de la campagne ont multiplié en vain les JNV pensant finir par venir à bout des résistances, mais celles-ci ont laissé des poches de population insuffisamment vaccinée, ce qui a permis au virus sauvage de demeurer endémique et à la nouvelle épidémie de virus dérivés du vaccin de progresser. Nous pouvons nous poser la question de ce que la campagne serait devenue si ses organisateurs avaient pris le temps de la réflexion et réorienté leur stratégie pour s'appuyer sur la vaccination de routine du Programme élargi de vaccination, qui ne suscite pas de telles oppositions.
Keywords: Eradiction; Inactivated poliovirus vaccine (IPV); Oral poliovirus vaccine (OPV); Poliomyelitis; Resistance; Vaccination.
Copyright © 2023 SFMTSI.
Conflict of interest statement
L'auteur ne déclare aucun lien d'intérêts.
Figures
Similar articles
-
Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.Pediatr Clin North Am. 2000 Apr;47(2):287-308. doi: 10.1016/s0031-3955(05)70208-x. Pediatr Clin North Am. 2000. PMID: 10761505 Review.
-
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25. MMWR Recomm Rep. 1997. PMID: 9026708
-
Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication.J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S398-S404. doi: 10.1093/infdis/jiaa622. J Infect Dis. 2021. PMID: 34590135 Free PMC article.
-
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.BMC Infect Dis. 2016 Jun 1;16:237. doi: 10.1186/s12879-016-1537-8. BMC Infect Dis. 2016. PMID: 27246198 Free PMC article.
-
Epidemiology of poliomyelitis--options and update.Vaccine. 2008 Oct 23;26(45):5767-73. doi: 10.1016/j.vaccine.2008.07.101. Epub 2008 Aug 26. Vaccine. 2008. PMID: 18755232 Review.
References
-
- Aylward BR, Sutter RW, Cochi SL, Thompson KM, Jafari H, Heymann D. Risk management in a polio-free world. Risk Anal. 2006 Dec;26(6):1441–1448. 10.1111/j.1539-6924.2006.00840.x . - DOI - PubMed
-
- Bello Z, Adamu YM, Abdulkarim IA. Measles immunization coverage in Kano State, Nigeria: a geographical analysis. GOJGES. 2020;1(3):585–594. www.gojgesjournal.com/upload/Vol%2001%20No.%2003%2009.pdf .
-
- Centers for Disease Control and Prevention What is polio? www.cdc.gov/polio/what-is-polio [Consulté le 30/10/2022]
-
- Chumakov K, Ehrenfeld E, Agol VI, Wimmer E. Polio eradication at the crossroads. Lancet Glob Health. 2021 Aug;9(8):e1172–e1175. 10.1016/S2214-109X(21)00205-9 . - DOI - PubMed
-
- Cooper LV, Bandyopadhyay AS, Gumede N, Mach O, Mkanda P, Ndoutabé M, Okiror SO, Ramirez-Gonzalez A, Touray K, Wanyoike S, Grassly NC, Blake IM. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. Lancet Infect Dis. 2022 Feb;22(2):284–294. 10.1016/S1473-3099(21)00453-9. Erratum in: Lancet Infect Dis. 2022 Feb, 22(2):e41. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical